When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. Respiratory syncytial virus vaccine - Wikipedia

   en.wikipedia.org/wiki/Respiratory_syncytial...

   A respiratory syncytial virus vaccine, or RSV vaccine, is a vaccine that protects against respiratory syncytial virus. [1] RSV affects an estimated 64 million people and causes 160,000 deaths worldwide each year. [2] The RSV vaccines Arexvy , [3] Abrysvo , [4] and Mresvia [5] are approved for medical use in the United States.

3. Timeline of human vaccines - Wikipedia

   en.wikipedia.org/wiki/Timeline_of_human_vaccines

   2013 – First vaccine for enterovirus 71, one cause of hand, foot, and mouth disease [18] 2015 – First vaccine for malaria [19] 2015 – First vaccine for dengue fever [20] 2019 – First vaccine for Ebola approved [21] 2020 – First vaccine for COVID-19; 2023 – First respiratory syncytial virus vaccine; 2023 - First vaccine for Chikungunya

4. Respiratory syncytial virus - Wikipedia

   en.wikipedia.org/wiki/Respiratory_syncytial_virus

   Respiratory syncytial virus (RSV), [a] also called human respiratory syncytial virus (hRSV) and human orthopneumovirus, is a virus that causes infections of the respiratory tract. It is a negative-sense, single-stranded RNA virus. [2] Its name is derived from the large cells known as syncytia that form when infected cells fuse. [2] [3]

5. Drugmaker seeks approval for RSV vaccine for 50-59 year olds

   www.aol.com/drugmaker-seeks-approval-rsv-vaccine...

   Drugmaker GSK said its RSV, or respiratory syncytial virus, vaccine Arexvy is safe and effective for adults ages 50-59 who have a higher risk of complications from RSV. GSK submitted findings from ...

6. CDC advisers narrow age recommendation for RSV shots in US - AOL

   www.aol.com/news/us-advisers-consider-rsv-shots...

   (Reuters) -A panel of outside experts to the U.S. CDC on Wednesday narrowed its recommendation for use of respiratory syncytial virus vaccines in older adults this year and held off on ...

7. FDA Approves Pfizer's Respiratory Syncytial Virus Vaccine ...

   www.aol.com/fda-approves-pfizers-respiratory...

   On Tuesday, the FDA approved Pfizer Inc’s (NYSE:PFE) Abrysvo (Respiratory Syncytial Virus Vaccine), the company’s bivalent RSV prefusion F (RSVpreF) vaccine, to prevent lower respiratory tract ...